open access
Prevalence of hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) in the population of adult asthmatics in Poland based on an epidemiological questionnaire
open access
Abstract
Introduction: Hypersensitivity reactions to drugs account for 25% of all side effects related to drugs, affecting more than 7% of the population. One in four such reactions is caused by acetylic acid and other non-steroidal anti-inflammatory drugs.
Material and methods: Between 1998 and 2000 epidemiological research was carried out in various centers, with the aim of estimating the frequency of allergy-based diseases in Poland. The objective of the study was to evaluate the frequency of hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs), based on an epidemiological questionnaire, in the Polish adult population.
Results: Bronchial asthma was diagnosed in 582 patients (5.4%). Of that group, 75 patients (12.9%) additionally reported symptoms of hypersensitivity to NSAIDs. Aspirin-induced asthma was diagnosed in 11 patients (14.7%) with clinical manifestations of hypersensitivity responses. Frequency of aspirin-induced asthma with clinical symptoms amounted to 1.9% of asthmatics. In the assessment of severity of the disease, aspirin intolerance was the only statistically significant factor (p = 0.0003; odds ratio 28.6 with assumed 95% confidence interval).
Conclusions: In the population of adults in Poland, the frequency of aspirin-induced asthma amounted to 0.1%. Hypersensitivity to NSAIDs was observed in 12.9% of asthmatics. In asthmatics with symptoms of hypersensitivity to non-steroidal anti-inflammatory drugs, which takes the course of clinically demonstrable aspirin-induced asthma, the risk of severe asthma is 30-fold higher.
Abstract
Introduction: Hypersensitivity reactions to drugs account for 25% of all side effects related to drugs, affecting more than 7% of the population. One in four such reactions is caused by acetylic acid and other non-steroidal anti-inflammatory drugs.
Material and methods: Between 1998 and 2000 epidemiological research was carried out in various centers, with the aim of estimating the frequency of allergy-based diseases in Poland. The objective of the study was to evaluate the frequency of hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs), based on an epidemiological questionnaire, in the Polish adult population.
Results: Bronchial asthma was diagnosed in 582 patients (5.4%). Of that group, 75 patients (12.9%) additionally reported symptoms of hypersensitivity to NSAIDs. Aspirin-induced asthma was diagnosed in 11 patients (14.7%) with clinical manifestations of hypersensitivity responses. Frequency of aspirin-induced asthma with clinical symptoms amounted to 1.9% of asthmatics. In the assessment of severity of the disease, aspirin intolerance was the only statistically significant factor (p = 0.0003; odds ratio 28.6 with assumed 95% confidence interval).
Conclusions: In the population of adults in Poland, the frequency of aspirin-induced asthma amounted to 0.1%. Hypersensitivity to NSAIDs was observed in 12.9% of asthmatics. In asthmatics with symptoms of hypersensitivity to non-steroidal anti-inflammatory drugs, which takes the course of clinically demonstrable aspirin-induced asthma, the risk of severe asthma is 30-fold higher.
Keywords
asthma; prevalence; aspirin induced asthma; non-steroidal anti-inflammatory drugs; hypersensitivity


Title
Prevalence of hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) in the population of adult asthmatics in Poland based on an epidemiological questionnaire
Journal
Advances in Respiratory Medicine
Issue
Article type
Research paper
Pages
431-439
Published online
2009-08-12
Bibliographic record
Pneumonol Alergol Pol 2009;77(5):431-439.
Keywords
asthma
prevalence
aspirin induced asthma
non-steroidal anti-inflammatory drugs
hypersensitivity
Authors
Łukasz Kasper
Krzysztof Sładek
Grażyna Bochenek
Mariusz Duplaga
Andrzej Szczeklik


- Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol. 2005; 5(4): 309–316.
- Faich GA. Adverse-drug-reaction monitoring. N Engl J Med. 1986; 314(24): 1589–1592.
- Johansson SG, Hourihane JO, Bousquet J, et al. EAACI (the European Academy of Allergology and Cinical Immunology) nomenclature task force. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 2001; 56(9): 813–824.
- Stevenson DD, Sanchez-Borges M, Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol. 2001; 87(3): 177–180.
- Widal F, Abrami P, Lermoyez J. Anaphylaxie et idiosyncrasie. Press Medical. 1922; 30: 189–192.
- Samter M, Beers RF. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968; 68(5): 975–983.
- Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol. 2006; 118(4): 773–786.
- Szczeklik A, Niżankowska-Mogilnicka E, Sanak M. Hypersensitivity to aspirin and others NSAIDS’. In: Kay AB, Kaplan AP, Bousquet J, Holt PG. ed. Allergy and allergic diseases. Blackwell Publ , London 2008: 1966–1980.
- Grzelewska-Rzymowska I, Szmidt M, Rożniecki J. Pokrzywka z nadwrażliwością na aspirynę; studium kliniczne. Pneumonol Alergol Pol. 1993; 61: 25–28.
- James J, Waris R. Chronic Urticaria: The Effect of Aspirin. British Journal of Dermatology. 1970; 82(2): 204–205.
- Mastalerz L, Setkowicz M, Sanak M, et al. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol. 2004; 113(4): 771–775.
- Zembowicz A, Mastalerz L, Setkowicz M, et al. Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. Arch Dermatol. 2003; 139(12): 1577–1582.
- Hedman J, Kaprio J, Poussa T, et al. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol. 1999; 28(4): 717–722.
- Vally H, Taylor ML, Thompson PJ. The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients. Thorax. 2002; 57(7): 569–574.
- Beasley R. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The Lancet. 1998; 351(9111): 1225–1232.
- Ellwood P, Asher MI, Beasley R, et al. ISAAC Steering Committee. The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods. Int J Tuberc Lung Dis. 2005; 9(1): 10–16.
- Asher MI, Keil U, Anderson HR, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J. 1995; 8(3): 483–491.
- Maziak W, Behrens T, Brasky TM, et al. Are asthma and allergies in children and adolescents increasing? Results from ISAAC phase I and phase III surveys in Münster, Germany. Allergy. 2003; 58(7): 572–579.
- Peat JK, Haby M, Spijker J, et al. Prevalence of asthma in adults in Busselton, Western Australia. BMJ. 1992; 305(6865): 1326–1329.
- Burney P, Malmberg E, Chinn S, et al. The distribution of total and specific serum IgE in the European Community Respiratory Health Survey. J Allergy Clin Immunol. 1997; 99(3): 314–322.
- Chinn S, Burney P, Jarvis D, et al. Variation in bronchial responsiveness in the European Community Respiratory Health Survey (ECRHS). European Respiratory Journal. 1997; 10(11): 2495–2501.
- Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). European Respiratory Journal. 1996; 9(4): 687–695.
- Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J. 2000; 16(3): 432–436.
- Marquette CH, Saulnier F, Leroy O, et al. Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis. 1992; 146(1): 76–81.
- Picado C, Castillo JA, Montserrat JM, et al. Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation. Eur Respir J. 1989; 2(2): 127–129.
- Małolepszy J, Liebhart J, Wojtyniak B, et al. Występowanie chorób alergicznych w Polsce. Alergia Astma Immunologia. 2000; 5(supl. 2): 163–169.
- Liebhart J, Malolepszy J, Wojtyniak B, et al. Polish Multicentre Study of Epidemiology of Allergic Diseases. Prevalence and risk factors for asthma in Poland: results from the PMSEAD study. J Investig Allergol Clin Immunol. 2007; 17(6): 367–374.
- Schubert B, Grosse Perdekamp MT, Pfeuffer P, et al. Nonsteroidal anti-inflammatory drug hypersensitivity: fable or reality? Eur J Dermatol. 2005; 15(3): 164–167.
- Kalyoncu AF, Karakaya G, Sahin AA, et al. Occurrence of allergic conditions in asthmatics with analgesic intolerance. Allergy. 1999; 54(5): 428–435.
- Naesdal J, Brown K. NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options. Drug Saf. 2006; 29(2): 119–132.
- Langman MJ. Epidemiology of non-steroidal anti-inflammatory drug damage to stomach and duodenum. Ital J Gastroenterol Hepatol. 1999; 31 Suppl 1: S2–S5.
- Tenenbaum J. The epidemiology of nonsteroidal anti-inflammatory drugs. Can J Gastroenterol. 1999; 13(2): 119–122.
- Peura DA. Prevention of nonsteroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complications. Am J Med. 2004; 117 Suppl 5A: 63S–71S.
- Kasper Ł, Sładek K, Bochenek G, et al. Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland. Allergy. 2003; 58(10): 1064–1066.
- CHAFEE F, SETTIPANE G. Aspirin intolerance I. Frequency in an allergic population. Journal of Allergy and Clinical Immunology. 1974; 53(4): 193–199.
- Settipane GA, Chafee FH, Klein DE. Aspirin intolerance. II. A prospective study in an atopic and normal population. J Allergy Clin Immunol. 1974; 53(4): 200–204.
- Giraldo B, Blumenthal MN, Spink WW. Aspirin intolerance and asthma. A clinical and immunological study. Ann Intern Med. 1969; 71(3): 479–496.
- Barnes PJ, Woolcock AJ. Difficult asthma. Eur Respir J. 1998; 12(5): 1209–1218.